The effect of methylphenidate, atomoxetine and citalopram versus placebo on behavioural and physiological indices of executive control in healthy individuals.
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Atomoxetine (Primary) ; Citalopram (Primary) ; Methylphenidate (Primary)
- Indications Anxiety disorders; Attention-deficit hyperactivity disorder; Depressive disorders; Huntington's disease; Social phobia; Somatoform disorders
- Focus Pharmacodynamics
- 28 Jun 2012 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
- 04 Aug 2009 New trial record